or not treated (n= 12) with aspirin and healthy untreated control pigs (n= 15). Neutropenia was achieved by treatment with cyclophosphamide (50 mg/kg, 4 days before the experiment), which decreased circulating leukocyte count by 92% and almost abolished neutrophil aggregation to N-formylmethionyl-leucyl-phenylalanine without affecting blood platelet count, hematocrit, hemoglobin concentration, or whole blood platelet aggregation to ADP. 51Cr platelet deposition on deeply injured and uninjured arterial segments was not statistically influenced by neutrophil depletion, whereas the angiographic vasoconstrictive response at the site of endothelial injury distally was significantly reduced by 41% from 46.3+2.9% in the control group to 27 .2+4.1% in the neutropenic group (P<.05). Aspirin treatment in combination with neutropenia produced a 50% reduction in whole blood platelet aggregation, resulted in a significant inhibition of platelet deposition to deeply injured arteries, and decreased vasoconstriction by 66% to 15 Key Words * platelets * neutropenia * arterial injury . vasoconstriction P latelet and leukocyte interactions with the intact and injured arterial wall have been implicated in thrombogenesis, inflammation, vasospasm, atherosclerosis, and restenosis.'-5 The response to an acute arterial injury in vivo by the formation of a mural thrombus and a localized vasoconstrictive response are largely influenced by platelet adhesion and activation.1-3 The extent of platelet deposition is modulated by the severity of arterial injury and is correlated positively with the injury-related vasoconstrictive response, and both platelet deposition and vasoconstriction are inhibited by aspirin.2'3 Although the inhibition of platelets in these studies2'3 or the depletion of platelets in other studies using thrombocytopenic animals6 have suggested an important role for platelets in the arterial responses to injury, these interventions do not totally inhibit the arterial vasoconstrictive response occurring at the site of endothelial injury,2'3'6 thereby suggesting the existence of a platelet-independent pathway mediating vasoconstriction in vivo. Other cellular elements such as neutrophils are also believed to participate in the pathogenesis of thrombosis by activating platelets through the release of neutrophil-derived products such as plateletactivating factor (PAF), free radicals, proteolytic enzymes, and leukotrienes.4 '7,8 These products secreted by © 1994 American Heart Association, Inc. activated neutrophils can amplify the arterial response to injury. We have previously demonstrated that similar to platelet interactions with the injured vessel wall, neutrophil adhesion to injured arteries is time and shear rate dependent9 and is reduced after thrombocytopenia.6 Increasing evidence also suggests that neutrophils are implicated in vascular tone regulation.4"10" Activated neutrophils may also enhance the generation of thromboxane A2, a potent platelet-derived vasoconstrictor.'2 These findings suggest a close interaction among platelets, neutrophils, and the injured arterial wall.
Neutrophil implication in ischemic heart disease and reperfusion injury and in many inflammatory processes has been studied using a variety of strategies including the use of anti-inflammatory drugs,13.14 neutrophil depletion by antiseral5, 16 
Isolation and Labeling of Platelets
In all animals, 100 mL of autologous blood collected in 15-mL acid citrate dextrose was used for isolation and radiolabeling of platelets with`1Cr (Merck Frosst) as previously described.9 Briefly, a platelet-rich plasma was 
Carotid Arterial Injury
Carotid arterial injury by balloon angioplasty was begun approximately 2 hours after the injection of the radiolabeled platelets and was performed using a 7F polyethylene balloon dilatation catheter (size, 8 mmx3 cm, Meditech Inc).23 After a single bolus of heparin (100 USP U/kg), the catheter was advanced under fluoroscopic control through the right femoral artery into the left and the right common carotid arterial segments between the fifth and fourth cervical vertebrae. Five inflations were performed at 6 atm pressure, each for 30 seconds with 60-second intervals between inflations.2,3 The vasoconstrictive response localized at the site of the distal tapering end of the balloon, where endothelial injury occurred without any balloon stretching of the arterial wall, was quantified using angiograms obtained before and after the dilatation. 23 The vasoconstrictive response was defined as the lumen diameter after dilatation and expressed as percentage of lumen diameter before dilatation.
Quantification of Platelet Deposition
Immediately after the angioplasty procedure, the carotid arteries were fixed in situ with a buffered solution of 2% glutaraldehyde and 1% paraformaldehyde perfused anterogradely. The The balloon-to-artery ratio, determined angiographically by dividing the diameter of the balloon during dilatation by the diameter of the artery before dilatation, also was statistically similar for the groups (P=NS).
Discussion
Carotid arterial wall injury induced at the site of the maximally inflated balloon at 6 atm pressure produces a histologically severe arterial lesion that exposes the arterial media to flowing blood. This arterial injury is analogous to the deep or type III injury as classified by Fuster et al24 and is characterized by rupture of the internal elastic lamina, exposing the highly thrombogenic medial components to the circulation. Cellular blood elements such as platelets interact with the injured vessel wall, leading to the acute formation of a mural thrombus.2,3,9 Secretion of potent vasoactive substances, such as thromboxane A2, serotonin, ADP, and PAF, from the activated adherent platelets may contribute further to the arterial vasoconstrictive response occurring at the site of endothelial injury in vivo. 12 Other cellular elements, such as neutrophils, also can Selective neutrophil depletion was successfully produced by the cyclophosphamide treatment, which resulted in severe neutropenia without affecting blood platelet and erythrocyte counts and the hemoglobin or hematocrit. Platelet function was not directly affected, as demonstrated by the platelet aggregation response to ADP, which was similar before and after neutropenia. In addition, platelet deposition at the site of deep arterial injury was similar in the control and neutropenic groups of animals, and platelet interaction with the uninjured arterial segments with intact endothelium was low and not influenced by cyclophosphamide treatment. Although platelet number and function were unchanged, the induction of severe neutropenia was accompanied by an almost complete inhibition of neutrophil aggregation to FMLP and by a 41% reduction in the arterial vasoconstrictive response at the site of endothelial injury. Although inhibition of platelet function can inhibit the injury-related vasoconstrictive response, the present study shows that this vasoconstrictive response in vivo can also be inhibited by marked depletion and inhibition of neutrophil function without affecting platelet count or function. These results provide experimental evidence implicating neutrophils in the vasoconstrictive response associated with endothelial injury in vivo and extend observations showing the vasomotor influences of neutrophils when exposed to arterial rings in organ bath experiments.10"1125 A further 25% reduction (P<.05) in the vasoconstrictive response was observed when platelet function was inhibited with aspirin in conjunction with production of neutropenia. Aspirin treatment plus neutropenia was also associated with almost 50% significant reduction in platelet aggregation and deposition. Aspirin alone, without concomitant neutropenia, has previously been shown to decrease platelet deposition and reduce the associated arterial vasoconstrictive response in this porcine model. 2 Activation of neutrophils has also been associated with the pathophysiological events occurring after balloon angioplasty in humans. In summary, the present study demonstrated that neutrophil depletion that does not affect circulating platelet count or function significantly decreased the vasoconstrictive response associated with arterial injury. This is the first direct experimental evidence implicating neutrophils in vascular tone regulation at the site of endothelial injury in vivo. Inhibition of neutrophil and platelet function may provide a way to limit many of the adverse pathophysiological events associated with arterial injury in vivo.
